Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 370 (2) , 653-662
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Adaptive Redox Response of Mesenchymal Stromal Cells to Stimulation with Lipopolysaccharide Inflammagen: Mechanisms of Remodeling of Tissue Barriers in SepsisOxidative Medicine and Cellular Longevity, 2013
- The Cannabinoid Receptor Type 1 Is Essential for Mesenchymal Stem Cell Survival and Differentiation: Implications for Bone HealthStem Cells International, 2013
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stressFree Radical Biology and Medicine, 2011
- How does the oxidative burst of macrophages kill bacteria? Still an open questionMolecular Microbiology, 2011
- New concepts on the immune modulation mediated by mesenchymal stem cellsStem Cell Research & Therapy, 2010
- Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic PotentialMediators of Inflammation, 2010
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial CellsJournal of Biological Chemistry, 2010
- Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density LipoproteinCirculation Research, 2009
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Antimicrobial reactive oxygen and nitrogen species: concepts and controversiesNature Reviews Microbiology, 2004